1. Home
  2. MPAA vs CABA Comparison

MPAA vs CABA Comparison

Compare MPAA & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Motorcar Parts  of America Inc.

MPAA

Motorcar Parts of America Inc.

HOLD

Current Price

$15.53

Market Cap

290.7M

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$3.04

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPAA
CABA
Founded
1968
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
290.7M
319.6M
IPO Year
2007
2019

Fundamental Metrics

Financial Performance
Metric
MPAA
CABA
Price
$15.53
$3.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$17.50
$14.50
AVG Volume (30 Days)
148.5K
4.1M
Earning Date
06-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
162.63
10.26
EPS
0.62
N/A
Revenue
$789,806,000.00
N/A
Revenue This Year
$1.50
N/A
Revenue Next Year
$7.42
N/A
P/E Ratio
$24.05
N/A
Revenue Growth
4.28
N/A
52 Week Low
$9.29
$1.26
52 Week High
$18.12
$4.23

Technical Indicators

Market Signals
Indicator
MPAA
CABA
Relative Strength Index (RSI) 69.74 44.54
Support Level $15.14 $2.74
Resistance Level $16.13 $3.34
Average True Range (ATR) 0.99 0.22
MACD 0.09 -0.01
Stochastic Oscillator 96.10 45.08

Price Performance

Historical Comparison
MPAA
CABA

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts, test solutions, and diagnostic equipment. Its replacement parts are mainly sold to automotive retail chain stores, warehouse distributors across North America, and automobile manufacturers for aftermarket and warranty replacement programs. The Company's test solutions and diagnostic equipment serve the automotive component and powertrain testing market. Its product portfolio includes rotating electrical products such as alternators and starters; brake-related products including brake calipers, brake rotors, brake pads, brake master cylinders, and wheel hub assemblies and bearings; and other products. Its segments are Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: